SCHEDULE 13G/A

Terns Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 880881107

Event date: 2025-01-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Vivo Capital Fund VIII, L.P.

  Shares: 966,461.00 · Class: 0.9%

• Vivo Capital Surplus Fund VIII, L.P.

  Shares: 133,415.00 · Class: 0.1%

• Vivo Capital VIII, LLC

  Shares: 1,099,876.00 · Class: 1.0%

• Vivo Opportunity Fund Holdings, L.P.

  Shares: 2,700,615.00 · Class: 2.5%

• Vivo Opportunity, LLC

  Shares: 2,700,615.00 · Class: 2.5%

• Vivo Opportunity Cayman Fund, L.P.

  Shares: 241,652.00 · Class: 0.2%

• Vivo Opportunity Cayman, LLC

  Shares: 241,652.00 · Class: 0.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.